厄洛替尼联合贝伐珠单抗治疗EGFR突变晚期非小细胞肺癌患者的有效性和安全性的Meta分析
胥昕怡, 占美, 张晟肇, 秦舟, 戴冰, 徐珽
Meta-analysis of efficacy and safety of erlotinib plus bevacizumab for advanced non-small cell lung cancer patients with EGFR-positive mutations
XU Xin-yi, ZHAN Mei, ZHANG Sheng-zhao, QIN Zhou, DAI Bing, XU Ting
中国医院药学杂志
.
2021, (16): 1658
-1664
.
DOI: 10.13286/j.1001-5213.2021.16.11
